Jennifer Bushen, Janssen Scientific Affairs, LLC

Janssen Scientific Affairs, LLC
Jennifer Bushen is the Medical Communication Manager at Janssen Scientific Affairs, Infectious Diseases. She earned her PharmD from Duquesne University, completed her ID Residency at the Hospital of the Univ of Pennsylvania and worked as an ID Pharmacy Specialist at Christiana Care Health System.

Presenter Of 1 Presentation

Oral poster discussion session

PDB0202 - Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis

Room
Abstract Sessions On-Demand Channel

Presenter Of 1 Presentation

Oral poster discussion session

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis

Room
Abstract Sessions On-Demand Channel

Presenter Of 1 Presentation

Oral poster discussion session

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-naïve (AMBER) and virologically suppressed (EMERALD) patients with neurologic and/or psychiatric comorbidities: Week 96 subgroup analysis

Room
Abstract Sessions On-Demand Channel